(Q44513272)

English

Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: A 15-year experience

scientific article published on October 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: a 15-year experience (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: A 15-year experience (English)

1 reference

10.1016/S0301-472X(03)00231-5

https://api.crossref.org/works/10.1016/S0301-472X(03)00231-5

20 March 2024

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

total body irradiation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550815

20 March 2024

1 reference

10.1016/S0301-472X(03)00231-5

https://api.crossref.org/works/10.1016/S0301-472X(03)00231-5

20 March 2024

1 reference

10.1016/S0301-472X(03)00231-5

https://api.crossref.org/works/10.1016/S0301-472X(03)00231-5

20 March 2024

author name string

Catriona H. M. Jamieson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550815

20 March 2024

Michael D. Amylon

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550815

20 March 2024

Ruby M. Wong

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550815

20 March 2024

Karl G. Blume

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550815

20 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14550815

20 March 2024

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

full work available at URL

http://www.exphem.org/article/S0301472X03002315/pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550815

20 March 2024

https://api.elsevier.com/content/article/PII:S0301472X03002315?httpAccept=text/xml

1 reference

10.1016/S0301-472X(03)00231-5

https://api.crossref.org/works/10.1016/S0301-472X(03)00231-5

20 March 2024

https://api.elsevier.com/content/article/PII:S0301472X03002315?httpAccept=text/plain

1 reference

10.1016/S0301-472X(03)00231-5

https://api.crossref.org/works/10.1016/S0301-472X(03)00231-5

20 March 2024

Experimental Hematology

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

981-986

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900231-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900231-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900231-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of chromosomal translocations on prognosis in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900231-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900231-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900231-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900231-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Equivalence of 2 effective graft-versus-host disease prophylaxis regimens: results of a prospective double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900231-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900231-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900231-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900231-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL).

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900231-5

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose etoposide (VP-16)-containing preparatory regimens in allogeneic and autologous bone marrow transplantation for hematologic malignancies

11

1 reference

10.1016/S0301-472X(03)00231-5

https://api.crossref.org/works/10.1016/S0301-472X(03)00231-5

20 March 2024

Identifiers

10.1016/S0301-472X(03)00231-5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44513272&oldid=2106639252"